Literature DB >> 12785419

Black-white differences in survival from late-stage prostate cancer.

Anthony P Polednak1.   

Abstract

OBJECTIVE: To examine differences between African Americans (Blacks) and non-Hispanic Whites in risk of death after diagnosis of later-stage prostate cancer in a large sample of patients from US population-based cancer registries. The theory that Black patients with advanced cancer have a lower survival rate compared to their White counterparts, based on a single clinical trial, was tested with large samples of patients.
METHODS: The Cox proportional hazards regression model was used to compare survival rates among 24,136 non-Hispanic White, and 3,817 Black prostate cancer patients diagnosed between 1988 and 1997, whose cancer had spread beyond the prostate capsule, and who resided in 9 geographic areas covered by the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program of population-based cancer registries. Other analyses involved 5- and 10-year relative survival rates (RSRs) among non-Hispanic White and Black patients diagnosed with distant-stage prostate cancer from 1973 to 1994 (with almost all patients having had a chance to survive for at least 5 years).
RESULTS: The risk of death from prostate cancer was only slightly higher for Blacks than for Whites (adjusted hazard rate ratio = 1.05), when age, extent of disease, tumor grade, marital status, and surgery were included in the Cox proportional hazards regression model. Five- and 10-year RSRs were about 2%-22% higher for Blacks and Whites in strata defined by extent of disease, or among patients with distant stage cancer, but differences were small among married patients.
CONCLUSIONS: The findings do not indicate substantial Black-White differences in survival rates of later-stage prostate cancer patients, after adjusting for clinical characteristics and marital status.

Entities:  

Mesh:

Year:  2003        PMID: 12785419

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  7 in total

1.  Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer.

Authors:  Benjamin A Spencer; Beverly J Insel; Dawn L Hershman; Mitchell C Benson; Alfred I Neugut
Journal:  Support Care Cancer       Date:  2013-01-06       Impact factor: 3.603

2.  Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.

Authors:  Arica White; Ann L Coker; Xianglin L Du; Katherine S Eggleston; Melanie Williams
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

3.  Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer.

Authors:  Benjamin A Spencer; Jin Joo Shim; Dawn L Hershman; Brad E Zacharia; Emerson A Lim; Mitchell C Benson; Alfred I Neugut
Journal:  Support Care Cancer       Date:  2014-01-16       Impact factor: 3.603

4.  Community-based free prostate cancer screening program.

Authors:  Lina Jandorf; Matthew S Chang; Kayode Smith; Alexis Florio; Simon J Hall
Journal:  Prog Community Health Partnersh       Date:  2007

5.  Proteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues.

Authors:  Jennifer S Myers; Ariana K von Lersner; Qing-Xiang Amy Sang
Journal:  J Cancer       Date:  2016-07-05       Impact factor: 4.207

6.  Risk of Death from Prostate Cancer with and without Definitive Local Therapy when Gleason Pattern 5 is Present: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Jonathan Frandsen; Andrew Orton; Dennis Shrieve; Jonathan Tward
Journal:  Cureus       Date:  2017-07-10

7.  Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE).

Authors:  Sumedha Chhatre; Stanley Bruce Malkowicz; J Sanford Schwartz; Ravishankar Jayadevappa
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.